Valuation : OneSource Specialty Pharma Limited

Market Cap 176B 1.87B 1.61B 1.51B 1.38B 2.58B 2.59B 17.86B 6.93B 90.46B 7.01B 6.86B 291B P/E 2026
-229x
P/E 2027 * 38x
Enterprise Value 187B 1.98B 1.71B 1.6B 1.47B 2.74B 2.75B 18.96B 7.36B 96B 7.44B 7.28B 309B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.49x
Free-Float
64.51%
Yield 2026 *
-
Yield 2027 * -
1 day-2.41%
1 week+0.37%
Current month+1.23%
1 month-1.02%
3 months-14.07%
6 months+7.98%
Current year-15.07%
1 week 1,504.1
Extreme 1504.1
1,596.6
1 month 1,478
Extreme 1478
1,647
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
-2.41%+0.37%-17.91% - 1.87B
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average -1.07%+0.52%+63.83%+109.63% 27.69B
Weighted average by Cap. -1.04%+0.11%+88.65%+127.93%

Financials

2026 2027 *
Net sales 13.41B 142M 122M 115M 105M 197M 197M 1.36B 527M 6.88B 534M 522M 22.17B 21.8B 231M 199M 187M 171M 319M 320M 2.21B 857M 11.18B 867M 848M 36.03B
Net income -1.19B -12.61M -10.85M -10.21M -9.32M -17.44M -17.49M -121M -46.8M -611M -47.34M -46.31M -1.97B 4.46B 47.23M 40.64M 38.24M 34.93M 65.34M 65.52M 452M 175M 2.29B 177M 173M 7.37B
Net Debt 10.81B 114M 98.49M 92.67M 84.65M 158M 159M 1.1B 425M 5.54B 430M 420M 17.86B 8.86B 93.8M 80.71M 75.94M 69.37M 130M 130M 897M 348M 4.54B 352M 345M 14.64B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
26-09-04 ₹1,537.80 -2.41% 112,994
26-09-03 ₹1,575.70 +2.03% 118,656
26-09-02 ₹1,544.40 +1.08% 136,288
26-09-01 ₹1,527.90 +0.58% 69,898
26-08-31 ₹1,519.10 -0.85% 98,831
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,537.80INR
Average target price
2,056.00INR
Spread / Average Target
+33.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock